Cookson Peirce & Co. Inc. Reduces Stake in Cardinal Health, Inc. $CAH

Cookson Peirce & Co. Inc. lowered its position in Cardinal Health, Inc. (NYSE:CAH) by 0.6% during the second quarter, Holdings Channel.com reports. The institutional investor owned 244,162 shares of the company’s stock after selling 1,572 shares during the period. Cardinal Health accounts for approximately 1.8% of Cookson Peirce & Co. Inc.’s portfolio, making the stock its 16th biggest position. Cookson Peirce & Co. Inc.’s holdings in Cardinal Health were worth $41,019,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also recently bought and sold shares of the company. Principal Financial Group Inc. boosted its position in Cardinal Health by 5.3% in the first quarter. Principal Financial Group Inc. now owns 315,817 shares of the company’s stock valued at $43,510,000 after buying an additional 15,956 shares during the last quarter. Golden State Wealth Management LLC boosted its position in Cardinal Health by 569.5% in the 1st quarter. Golden State Wealth Management LLC now owns 395 shares of the company’s stock worth $54,000 after purchasing an additional 336 shares in the last quarter. North Capital Inc. purchased a new stake in Cardinal Health in the 1st quarter worth approximately $83,000. KLP Kapitalforvaltning AS boosted its position in Cardinal Health by 4.0% in the 2nd quarter. KLP Kapitalforvaltning AS now owns 114,198 shares of the company’s stock worth $19,185,000 after purchasing an additional 4,400 shares in the last quarter. Finally, Czech National Bank boosted its position in Cardinal Health by 5.1% in the 2nd quarter. Czech National Bank now owns 58,341 shares of the company’s stock worth $9,801,000 after purchasing an additional 2,857 shares in the last quarter. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have commented on CAH. Wells Fargo & Company restated an “overweight” rating and issued a $185.00 price objective (up previously from $183.00) on shares of Cardinal Health in a research report on Wednesday, August 13th. Morgan Stanley restated an “overweight” rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Robert W. Baird upped their target price on Cardinal Health from $197.00 to $203.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 13th. Evercore ISI reduced their target price on Cardinal Health from $200.00 to $190.00 and set an “outperform” rating for the company in a research note on Wednesday, August 13th. Finally, Weiss Ratings reaffirmed a “buy (b)” rating on shares of Cardinal Health in a research note on Wednesday, October 8th. Twelve equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Cardinal Health has an average rating of “Moderate Buy” and an average price target of $166.00.

Cardinal Health Stock Performance

NYSE CAH opened at $158.42 on Wednesday. The business has a fifty day moving average price of $152.10 and a 200 day moving average price of $152.15. Cardinal Health, Inc. has a one year low of $106.98 and a one year high of $168.44. The company has a market cap of $37.64 billion, a P/E ratio of 24.56, a P/E/G ratio of 1.33 and a beta of 0.71.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings data on Tuesday, August 12th. The company reported $2.08 EPS for the quarter, beating the consensus estimate of $2.03 by $0.05. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The firm had revenue of $60.16 billion during the quarter, compared to the consensus estimate of $60.91 billion. During the same period in the prior year, the company earned $1.84 EPS. The firm’s revenue was up .5% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. As a group, sell-side analysts predict that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st were paid a $0.5107 dividend. The ex-dividend date of this dividend was Wednesday, October 1st. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.3%. Cardinal Health’s dividend payout ratio (DPR) is 31.63%.

Insiders Place Their Bets

In other Cardinal Health news, insider Michelle D. Greene sold 13,500 shares of the firm’s stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total value of $2,009,070.00. Following the completion of the sale, the insider directly owned 14,976 shares of the company’s stock, valued at $2,228,728.32. This trade represents a 47.41% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Jason M. Hollar sold 35,901 shares of the firm’s stock in a transaction on Wednesday, August 20th. The stock was sold at an average price of $150.04, for a total value of $5,386,586.04. Following the completion of the sale, the chief executive officer directly owned 200,000 shares of the company’s stock, valued at $30,008,000. This trade represents a 15.22% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 271,676 shares of company stock worth $40,489,525. 0.12% of the stock is currently owned by company insiders.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.